A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
Clinical trial NCT06338995 · RECRUITING
Trial details
- NCT number
- NCT06338995
- Sponsor
- Eli Lilly and Company
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-29
- Primary completion
- 2027-05-01
- Enrollment
- 510
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.